"VRC is a research company – a group of research optometrists, technicians, and clinical coordinators that work with companies that make contact lenses.We’re committed to safely testing new contact lens materials and designs to bring more comfort, longer wearing times and improve the quality of vision for contact lens wearers. Research participants play an important role at VRC by helping bring new contact lens-related products to market. VRC is always looking for volunteers to participate in our studies. VRC values participant's time and opinion, therefore, compensation is provided while in the clinic. If interested please contact our facility."

During the past decade, VRC-East conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "VRC-East" are "Visual Acuity" (12 trials), "Ocular Physiology" (2 trials) and "Ametropia" (1 trials). Many other conditions were trialed in "VRC-East" in a lesser frequency.

Most popular intervention types in "VRC-East" are "Device" (15 trials). Other intervention types were less common.

The name of intervention was led by "Dailies Total 1® Multifocal Contact Lens" (2 trials), "senofilcon A" (2 trials), "1-DAY ACUVUE® DEFINE® Radiant Sweet™" (1 trials), "ACUVUE OASYS®1-Day with HydraLuxe™ Technology" (1 trials) and "ACUVUE® OASYS with Transitions™" (1 trials). Other intervention names were less common.

The vast majority of trials in "VRC-East" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "VRC-East". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in VRC-East, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VRC-East, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".